`
`U.S. Patent No. 8,017,150 (filed Apr. 22, 2008)
`
`File History, U.S. Patent No. 8,017,150
`
`U.S. Patent No. 4,713,243 (filed June 16, 1986) (“Schiraldi”)
`
`U.S. Patent No. 6,322,811 (issued November 27, 2001) (“Verma”)
`
`U.S. Patent No. 5,948,430 (filed August 1, 1997) (“Zerbe”)
`
`U.S. Patent No. 4,849,246 (issued July 18, 1989) (“Schmidt”)
`
`U.S. Patent No. 6,552,024 (filed November 5, 1999)
`
`U.S. Patent No. 4,764,378 (filed February 10, 1986) (“Keith”)
`
`U.S. Patent No. 5,273,758 (filed Apr. 13, 1992) (“Royce”)
`
`U.S. Patent No. 4,284,534 (filed October 24, 1980) (“’534 patent”)
`
`U.S. Patent No. 5,656,296 (filed August 12, 1997) (“Khan”)
`
`U.S. Patent No. 6,562,375 (filed August 1, 2000) (“Sako”)
`
`U.S. Patent Application Pub. No. US 2005/0037055 (published February 17, 2005)
`(“Yang”)
`
`U.S. Application No. 10/074,272 (filed February 14, 2002)
`
`U.S. Application No. 10/856,176 (filed May 28, 2004)
`
`U.S. Provisional Application No. 60/328,868
`
`U.S. Provisional Application No. 60/473,902
`
`U.S. Provisional Application No. 60/386,937 (filed June 27, 2002)
`
`U.S. Provisional Application No. 60/443,741 (filed January 30, 2003)
`
`U.S. Provisional Application No. 60/371,940 (filed April 11, 2002)
`
`U.S. Provisional Application No. 60/414,276.
`
`TEVA EXHIBIT 1048
`TEVA PHARMACEUTICALS USA, INC. V. MONOSOL RX, LLC
`
`
`
`Materials Considered by Nandita Das, Ph.D.
`
`PCT/US02/32542 (filed October 11, 2002)
`
`PCT/US02/32575 (filed October 11, 2002)
`
`PCT/US02/32594 (filed October 11, 2002)
`
`WO 2000/02955 (published January 20, 2000) (“Wang”)
`
`WO 00/42992 (published July 27, 2000) (“Chen”)
`
`EP No. 0,090,560 (published May 3, 1989) (“Mitra”)
`
`Suboxone® 2002 Label
`
`E.W. Flick, Water-Soluble Resins – An Industrial Guide (2nd ed. 1991) (“Flick”)
`
`Joint Claim Construction Chart, Reckitt Benckiser Pharmaceuticals Inc. v. Teva
`Pharmaceuticals USA, Inc., CA No. 14-1451-RGA (November 17, 2015), D.I. 91
`
`Proposed Joint Pre-Trial Order, Reckitt Benckiser Pharmaceuticals, Inc. et al. v.
`Watson Laboratories, Inc. et al. C.A. No. 13-cv-0167-RGA, D.I. 347
`
`R. Anders & H.P. Merkle, Evaluation of Laminated Muco-Adhesive Patches for
`Buccal Drug Delivery, 49 Int’l J. Pharmaceutics 231 (1989) (“Anders”)
`
`Viralkumar F. Patel et al., Advances in Oral Transmucosal Drug Delivery, 153 J.
`Controlled Release 106 (2011)
`
`Guo & Zerbe, Water-Soluble Film for Oral Administration, 13th International
`Symposium on Controlled Release of Bioactive Materials, 227 (1997) (“Guo”)
`
`S. Le Person et al., Near Infrared Drying of Pharmaceutical Thin Films:
`Experimental Analysis of Internal Mass Transport, 37 Chemical Engineering &
`Processing 257 (1998) (“Le Person”)
`
`Gary DeGrande et al., Specialized Oral Mucosal Drug Delivery Systems, in Oral
`Mucosal Drug Delivery (James Swarbrick, ed., 1995)
`
`A. Apicella et al., Poly(ethylene oxide) (PEO) and Different Molecular Weight
`PEO Blends Monolithic Devices for Drug Release, 14(2) Biomaterials 83 (1993)
`(“Apicella”)
`
`
`
`
`2
`
`TEVA EXHIBIT 1048
`TEVA PHARMACEUTICALS USA, INC. V. MONOSOL RX, LLC
`
`
`
`Materials Considered by Nandita Das, Ph.D.
`
`Hans P. Merkle et al., Mucoadhesive Buccal Patches for Peptide Delivery, in
`Bioadhesive Drug Delivery Systems (Vincent Lenaerts & Robert Gurny, eds.,
`1990)
`
`Remington’s Pharmaceutical Sciences (Alfonso R. Gennaro, ed.,17th ed. 1985)
`
`C.S. Fuller et al., Interactions in poly(ethylene oxide)—hydroxypropyl
`methylcellulose blends, 42 Polymer 9583 (2001) (“Fuller”)
`
`J.P. Cassidy et al., Controlled buccal delivery of buprenorphine, 25 J.Controlled
`Release 21 (1993) (“Cassidy”)
`
`Jian-Hwa Guo & K. M. Cooklock, Bioadhesive Polymer Buccal Patches for
`Buprenorphine Controlled Delivery: Solubility Consideration, 21(17) Drug Dev. &
`Indus. Pharmacy 2013 (1995) (“Guo & Cooklock”)
`
`Gordon L.Amidon et al., A Theoretical Basis for a Biopharmaceutic Drug
`Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo
`Bioavailability, 12(3) Pharmaceutical Res. 413 (1995) (“Amidon”)
`
`Marilyn N. Martinez & Gordon L. Amidon, A Mechanistic Approach to
`Understanding the Factors Affecting Drug Absorption: A Review of Fundamentals,
`42 J. Clinical Pharmacology 620 (2002) (“Martinez”)
`
`Robert O. Ebewele, Polymer Science and Technology (2000) (“Polymer Science
`and Technology”)
`
`Philip E. Slade, Jr., Polymer Molecular Weights (in two parts), Part I (1975)
`
`G.S. Misra, Introductory Polymer Chemistry (1993)
`
`Textbook of Polymer Science (2nd ed. 1971)
`
`Michael A. Repka & James W. McGinity, Influence of Vitamin E TPGS on the
`Properties of Hydrophilic Films Produced by Hot-Melt Extrusion, 202 Int’l J.
`Pharmaceutics 63 (2000) (“Repka”)
`
`
`
`
`
`
`3
`
`TEVA EXHIBIT 1048
`TEVA PHARMACEUTICALS USA, INC. V. MONOSOL RX, LLC